Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Irene Soloway"'
Autor:
Qinglu Cheng, Evan B. Cunningham, Sophy Shih, Janaki Amin, Julie Bruneau, Adelina A. Artenie, Jeff Powis, Alain H. Litwin, Curtis Cooper, Olav Dalgard, Margaret Hellard, Philip Bruggmann, Philippa Marks, Karine Lacombe, Catherine Stedman, Phillip Read, Behzad Hajarizadeh, Adrian J. Dunlop, Brian Conway, Jordan J. Feld, Gregory J. Dore, Jason Grebely, Gregory Dore, Sione Crawford, Tracy Swan, Jude Byrne, Melanie Lacalamita. Coordinating Centre—Amanda Erratt, Evan Cunningham, Pip Marks, Ineke Shaw, Sharmila Siriragavan, Sophie Quiene, Kathy Petoumenos, Patrick Schmid, Erika Castro, Alberto Moriggia, Jean-Pierre Daulouede, Christopher Fraser, Jordan Feld, Ed Gane, Gail Matthews, Adrian Dunlop, Ian Kronborg, David Shaw, Alain Litwin, Brianna Norton, Maria Christine Thurnheer, Martin Weltman, Philip Read, John Dillon, Simone Kessler, Cornelia Knapp, Lorenza Oprandi, Paola Messina, Marzia Pantic, Manuela Le Cam, Cecilia Maitre, Jessica Andreassen, Ingunn Melkeraaen, Merete Moen Tollefsen, Hannah Pagarigan, Rozalyn Milne, Kate Mason, Diana Kaznowski, Lily Zou, Rachel Bouchard, Barbara Kotsoros, Miriam Muir, Jessica Milloy, Victoria Oliver, Tracy Noonan, Alison Sevehon, Susan Hazelwood, Michelle Hall, Michelle Hagenauer, Rachel Liddle, Catherine Ferguson, Linda Agyemang, Hiral Patel, Irene Soloway, Orlando Cerocchi, Melanie Lacalamita, Vincenzo Fragomeli, Rosie Gilliver, Rebecca Lothian, Shirley Cleary, Linda Johnston, Sarah Middleton, Ronald D’Amico, Barbara McGovern, Jonathan Anderson, Ze Zhong, Fiona Keane, Fernando Tatsch, Diana Brainard, John McHutchison
Publikováno v:
Value in Health. 26:883-892
Autor:
L. Cockerham-Colas, Deena Peyser, S. P. Reynoso, Irene Soloway, Abigail W. Batchelder, Alain H. Litwin
Publikováno v:
Harm Reduction Journal
Harm Reduction Journal, Vol 14, Iss 1, Pp 1-7 (2017)
Harm Reduction Journal, Vol 14, Iss 1, Pp 1-7 (2017)
Background Although opioid-dependent patients are disproportionately impacted by hepatitis C (HCV), many do not receive treatment. In addition to HCV treatment-access barriers, substance-using patients may be reluctant to pursue treatment because of
Autor:
Robert J. Roose, Melissa R. Stein, Irene Soloway, Alain H. Litwin, Julia H. Arnsten, Karen S. Jefferson
Publikováno v:
Journal of Substance Abuse Treatment. 43:424-432
Chronic hepatitis C virus (HCV) infection is highly prevalent among current and former drug users. However, the minority of patients enrolled in drug treatment programs have initiated HCV treatment. New models are needed to overcome barriers to care.
Autor:
Philippe J. Zamor, Marc N. Gourevitch, Alain H. Litwin, Shadi Nahvi, Irene Soloway, Julia H. Arnsten, Kenneth A. Harris, Peter L. Tenore, Daniel Kaswan
Publikováno v:
Journal of Substance Abuse Treatment. 37:32-40
Injection drug users constitute 60% of the more than 4 million people in the United States with hepatitis C virus (HCV), including many methadone maintenance patients. Few data exist describing clinical outcomes for patients receiving HCV treatment o
Autor:
Moonseong Heo, Sheila Reynoso, Lauren Cockerham-Colas, Christopher Tenore, Irene Soloway, Robert J. Roose, Alain H. Litwin
Publikováno v:
The International journal on drug policy. 26(10)
Background People who inject drugs (PWID) constitute 10 million people globally with hepatitis C virus, including many opioid agonist treatment patients. Little data exist describing clinical outcomes for patients receiving HCV treatment with direct-
Autor:
Robert J. Roose, Abigail W. Batchelder, Lauren Cockerham-Colas, Alain H. Litwin, Irene Soloway
Publikováno v:
Journal of health care for the poor and underserved. 25(2)
This report describes an innovative HCV Peer Educator Program that facilitates education, support, and engagement in HCV treatment among patients in an opioid treatment program. Integrating peer educators in a collaborative manner with close supervis
Autor:
Marc N. Gourevitch, Julia H. Arnsten, Evelyn Du, Irene Soloway, Steven I. Berk, Alain H. Litwin
Publikováno v:
Clinical therapeutics. 29(1)
Background: Hepatitis C virus (HCV) infection is common among methadone-maintained HIV-positive individuals. Pegylated interferon (pegIFN) used in combination with ribavirin is conventional treatment for HCV. However, pegIFN has been associated with
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 40
Despite the high prevalence of hepatitis C virus (HCV) infection among drug users enrolled in methadone maintenance treatment programs, few drug users are being treated with combination therapy. The most significant barrier to treatment is lack of ac
Publikováno v:
Medical Education. 43:481-482